Drug
Azd0780
Azd0780: highest development phase Phase 3, developed by AstraZeneca. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| AZD0780 NCT07000136 | Phase 3 | Heterozygous Familial Hypercholesterolaemia |
| AZD0780 NCT06173570 | Phase 2 | Dyslipidemia |
| AZD0780 NCT06576765 | Phase 1 | Hepatic Impairment |
Latest
Follow Azd0780 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.